JP Morgan Chase
KZR

JP Morgan Chase’s Kezar Life Sciences KZR Stock Holding History

JP Morgan Chase’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,500
Closed -$646K – 6794
2022
Q3 		$646K Sell
7,500
-2,090
-22% -$203K ﹤0.01% 4292
2022
Q2 		$793K Buy
+9,590
New +$846K ﹤0.01% 4254

JP Morgan Chase's KZR Position: Q2 2026 in Review

JP Morgan Chase sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 109 shares — an estimated $812 sold.

JP Morgan Chase first reported a position in KZR in Q3 2018 and held it in 31 quarters. The position peaked at $9.11M in Q2 2022. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

  • JP Morgan Chase reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 109 Kezar Life Sciences shares in Q2 2026, an estimated $812.
  • JP Morgan Chase first reported a position in Kezar Life Sciences in Q3 2018 and held it in 31 quarters.
  • JP Morgan Chase's Kezar Life Sciences position peaked at $9.11M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.